Sandercock Colin

CIK 00017248701 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001724870

Recent Transactions

31 trades

Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2026-04-09+200,000→ 200,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2025-12-03+70,000→ 70,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2025-09-26+30,000→ 30,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2025-03-21+200,000→ 200,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2024-06-05+60,000→ 60,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2024-03-06+175,000→ 175,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2023-07-21+75,000→ 75,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2023-02-16+100,000→ 100,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2022-03-25+16,667→ 16,667 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2022-02-09+60,000→ 60,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2021-02-10+50,000→ 50,000 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Common Stock
2020-08-05$7.50/sh+13,374→ 30,499 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2020-08-05−13,374→ 130,000 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2020-08-05−13,274→ 130,100 total
Sale
Cue Biopharma, Inc.$CUE
Common Stock
2020-08-05$20.00/sh−13,374→ 17,125 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Common Stock
2020-08-05$7.50/sh+13,274→ 30,399 total
Sale
Cue Biopharma, Inc.$CUE
Common Stock
2020-08-05$20.00/sh−13,274→ 17,125 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2020-08-04−201→ 143,374 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Common Stock
2020-08-04$7.50/sh+201→ 17,326 total
Sale
Cue Biopharma, Inc.$CUE
Common Stock
2020-08-04$20.05/sh−201→ 17,125 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2020-08-03−6,425→ 143,575 total
Exercise/Conversion
Cue Biopharma, Inc.$CUE
Common Stock
2020-08-03$7.50/sh+6,425→ 23,550 total
Sale
Cue Biopharma, Inc.$CUE
Common Stock
2020-08-03$20.00/sh−6,425→ 17,125 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2020-02-05+20,000→ 20,000 total
Purchase
Cue Biopharma, Inc.$CUE
Common Stock
2019-06-10$7.90/sh+15,025→ 17,125 total
Purchase
Cue Biopharma, Inc.$CUE
Common Stock
2019-06-10$7.93/sh+14,938→ 16,938 total
Purchase
Cue Biopharma, Inc.$CUE
Common Stock
2019-06-07$7.35/sh+100→ 2,100 total
Purchase
Cue Biopharma, Inc.$CUE
Common Stock
2019-06-06$7.10/sh+2,000→ 2,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2019-03-06+50,000→ 50,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Option (right to buy)
2019-03-06+100,000→ 100,000 total
Award
Cue Biopharma, Inc.$CUE
Stock Options
2017-12-27+150,000→ 150,000 total

Companies

Cue Biopharma, Inc.
SVP, GENERAL COUNSEL
$CUE

Recent Filings

Address

C/O CUE BIOPHARMA, INC. 40 GUEST STREET

BOSTON, MA, 02135

View on SEC.gov